

Dr Oseme Etomi
Dr Oseme Etomi is an obstetric physician in London, UK, and works across three National Health System (NHS) trusts including Guy’s and St Thomas’, King’s and the Queen Elizabeth NHS hospital trusts.
Her background is in rheumatology and general medicine and her main field of interest is in obstetric rheumatology, looking after women with inflammatory rheumatic diseases (IRDs) in pregnancy.
Dr Etomi was trained in some of London’s most prestigious rheumatology centres, including the Royal Free Hospital (National Centre for Scleroderma and Other Connective Tissue Disorders) and Barts Health NHS Trust and the Royal London Hospital (National Centre of Inflammatory Arthritis and Systemic Lupus Erythematosus).
In 2017, Dr Etomi undertook a clinical fellowship at St Thomas’ Hospital, and she now runs a weekly Rheumatic Disease in Pregnancy clinic, seeing patients with the whole spectrum of IRDs.
Dr Etomi has published numerous abstracts and papers on IRDs and pregnancy. In 2018, she was awarded the best oral presentation at the International Society of Obstetric Medicine (ISOM) for her work in this field.
Dr Etomi was instrumental in setting up the British Society of Rheumatology (BSR) Special Interest Group in Pregnancy in 2019. She sits on the advisory board for the Biologics in Rheumatoid Arthritis in Pregnancy (BiRAP) group and is currently one of the organisers of the 12th Rheumapreg Symposium in September 2023 in London.
Accompany Dr Ann-Sophie De Craemer as she discusses management options for a patient with axSpA exhibiting few symptoms.
Work through the challenges in diagnosing suspected axSpA in two patient cases with Dr Michael Nissen and Dr Philipp Julian Bosch.
Join Dr Lykke Midtbøll Ørnbjerg as she explores the value of registry data for informing clinical practice in axSpA.
Watch Dr Floris van Gaalen explore whether early diagnosis of axSpA is possible, drawing on findings from the SPACE cohort.1

Setting up MDT care in HS: Learning from psoriasis
Establishing a multidisciplinary team to alleviate disease burden and optimise patient outcomes, using the principles of value-based healthcare

Use of imaging in HS management
Transformative role of ultrasound and magnetic resonance imaging in HS management, and how AI-driven technologies may enhance disease characterisation